GLP-1 drugs may reshape brain's dopamine reward system Beyond weight loss, research is pointing to broader effects on the brain
Some research suggests GIP might influence food reward pathways, but this remains an active area of investigation
Experiences can include changes in appetite, eating patterns, and energy levels, along with ongoing check-ins to assess how the body is responding
And that is exactly what GLP-1 does
Given the limitations of sample sizes and individual variability, these findings warrant careful interpretation [8]
The molecule is best understood not by its sequence alone but by its receptor target set: it binds and activates the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor [3]